NCT04654078View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

February 5, 2021

Study Completion Date

February 15, 2021

Conditions
Healthy
Interventions
DRUG

IN-C004 with water

One time dose of IN-C004 taken with water

DRUG

IN-C004 without water

One time dose of IN-C004 taken without water

DRUG

K-CAB tab. with water

One time dose of K-CAB tab. taken with water

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT04654078 - Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers | Biotech Hunter | Biotech Hunter